Jul 13, 2016 - On Wednesday, shares of Allergan (AGN) and Teva Pharmaceuticals (TEVA) are both on the rise, up around 2% and 3%, respectively, in morning trading after Teva CEO Erez Vigodman said it expects its $40.5 billion acquisition of Allergan's generics business to close any day.
Jul 13, 2016 - Ahead of its acquisition of Allergan's Generics business, Teva Pharmaceutical (TEVA) raised its second-quarter 2016 guidance for earnings and revenues.
Apr 06, 2016 - Allergan PLC (NYSE:AGN) Business Update Conference Call April 06, 2016 10:00 AM ET Executives Lisa DeFrancesco - VP, IR Brent Saunders - CEO & President Paul Bisaro - Executive Chairman Tessa Hila
Sep 23, 2015 - KYTHERA (KYTH) has filed an investigational new drug application for KYTH-105 for the treatment of male pattern hair loss.
Sep 18, 2015 - Allergan (AGN) and Gedeon Richter Plc. announced that the FDA has approved Vraylar for the treatment of bipolar I disorder and schizophrenia in adults.
Sep 11, 2015 - Apricus Biosciences' (APRI) shares gained 7.7% after the company regained the U.S. development and commercialization rights to Vitaros from Allergan.
Sep 11, 2015 - Apricus Biosciences (APRI) was a big mover last session with its shares rising roughly 8% on the day.
Sep 04, 2015 - Allergan plc (AGN) announced that it has entered into an agreement to acquire AqueSys, Inc.
Sep 03, 2015 - AstraZeneca (AZN) signs up with Daiichi Sankyo for FluMist Quadrivalent in Japan; reports positive phase III data on antibiotic drug CAZ-AVI.
Sep 01, 2015 - Allergan (AGN) acquires central nervous system focused company, Naurex, to boost mental disorder portfolio.